NPPA fixes retail price of 21 drugs including BP, diabetes, painkillers; Details
The NPPA order is likely to affect drug majors including Lupin, Emcure, Cipla, Mylan, Zydus, Macleods Pharmaceuticals.
New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 21 drug formulations. These formulations include diabetes drug, blood pressure drug, painkillers, emergency contraceptive for women.
The NPPA order is likely to affect drug majors including Lupin, Emcure, Cipla, Mylan, Zydus, Macleods Pharmaceuticals.
Some of the formulations whose price has been fixed by the NPPA are Metformin + Gliclazide Tablet manufactured by the Mumbai based Lupin. The formulation is used to treat type-2 diabetes, while the formulation Cilnidipine + Telmisartan + Chlorthalidone Tablet, manufactured by Emcure works by widening and relaxing the blood vessels, thereby lowering blood pressure.
The notification released by NPPA added that the manufacturer may add goods and services tax(GST) only if they have paid actually or it is payable to the Government on the retail price as mentioned.
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Escitalopram + Clonazepam Tablet (Andefre- LS) | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 5mg, Clonazepam IP 0.25mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Neomac Pharmaceuticals Pvt. Ltd. | 5.88 |
2. | Paracetamol + Aceclofenac Tablet | Each uncoated tablet contains: Paracetamol IP 325mg, Aceclofenac IP 100mg. | 1 Tablet | M/s Caplet India Private Limited | 3.35 |
3. | Misoprostol Tablet | Each uncoated tablets contains: Misoprostol 25mcg | 1 Tablet | M/s Acme Formulation Pvt. Ltd. / M/s Zydus Healthcare Limited | 4.37 |
4. | Mefenamic Acid + Paracetamol Tablet | Each uncoated tablets contains: Mefenamic Acid IP 500mg, Paracetamol IP 325mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 2.76 |
5. | Trastuzumab Injection | Each Lyophilized Vial contains: Trastuzumab 150mg | 1 Vial | M/s Cadila Healthcare Limited / M/s Glenmark Pharmaceuticals Limited | 18400.89 |
6. | Cilnidipine + Telmisartan + Chlorthalidone Tablet | Each film coated tablet contains: Cilnidipine IP 10mg, Telmisartan IP 40mg Chlorthalidone IP 6.25mg | 1 Tablet | M/s Windlas Biotech Pvt. Ltd. /M/s Emcure Pharmaceuticals Limited | 10.43 |
7. | Metformin + Gliclazide Tablet | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (in extended release | 1 Tablet | M/s Anphar Organics Pvt. Ltd. / M/s Lupin Limited | 6.31 |
form) Gliclazide IP 80mg (as modified release form) | |||||
8. | Metformin + Gliclazide Tablet | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (in extended release form) Gliclazide IP 60mg (as modified release form) | 1 Tablet | M/s Anphar Organics Pvt. Ltd. / M/s Lupin Limited | 8.64 |
9. | Telmisartan + Metoprolol Tablet (TELMELIFE – M25) | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release form) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Neomac Pharmaceuticals (P) Ltd. | 9.43 |
10. | Telmisartan + Metoprolol Tablet (TELMELIFE – M50) | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate (as extended release form) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Neomac Pharmaceuticals (P) Ltd. | 11.72 |
11. | Propranolol + Flunarizine Capsule | Each hard gelatine capsule contains: Propranolol Hydrochloride IP 40mg (as SR pellets), Flunarizine Dihydrochloride BP eq. to Flunarizine 5mg (as pellets) | 1 Capsule | M/s Innova Captab Ltd. / M/s Cipla Limited | 6.72 |
12. | Propranolol + Flunarizine Capsule | Each hard gelatine capsule contains: Propranolol Hydrochloride IP 40mg (as SR pellets), Flunarizine Dihydrochloride BP eq. to Flunarizine 10mg (as pellets) | 1 Capsule | M/s Innova Captab Ltd. / M/s Cipla Limited | 9.20 |
13. | Levonorgestrel Tablet | Each uncoated tablet contains: Levonorgestrel IP 1.5mg | 1 Tablet | M/s Mylan Laboratories Limited / M/s Mylan Pharmaceutical Private Limited | 92.80 |
14. | Formoterol + Budesonide Respirator suspension (Budetrol 0.5) | Each ml respule contains: Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 20mcg, Budesonide IP 0.5mg | Each 2 ML Pack | M/s Axa Parenterals Ltd. / M/s Macleods Pharmaceutical Limited | 36.04 |
15. | Formoterol + Budesonide Respirator suspension (Budetrol 1) | Each ml respule contains: Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 20mcg, Budesonide IP 1mg | Each 2 ML Pack | M/s Axa Parenterals Ltd. / M/s Macleods Pharmaceutical Limited | 42.12 |
16. | Metformin + Glimepiride Tablet (Geminor 0.5) | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg, (as Prolonged release form) Glimepiride IP 0.5mg | 1 Tablet | M/s Macleods Pharmaceutical Limited | 3.57 |
17. | Clobazam Suspension | Each ml suspension contains: Clobazam IP 2.5mg | 1 ML | M/s Intas Pharmaceutical Limited | 2.54 |
18. | Diclofenac + Chlorzoxazone Tablet (MYOSPAS-F ) | Each film coated tablet contains: Diclofenac Potassium BP 50mg Chlorzoxazone USP 500mg | 1 Tablet | M/s G. S. Pharmbutor Pvt. Ltd. /M/s Win- Medicare Pvt. Ltd. | 9.28 |
19. | Clonazepam Orally disintegrating Strips (Melzap ODS 0.5) | Each Orally disintegrating Strips contains: Clonazepam IP 0.5mg | 1 Orally disintegrating Strip | M/s ZIM Laboratories Limited / M/s Alkem Laboratories Ltd. | 5.33 |
20. | Clonazepam Orally disintegrating Strips (Melzap ODS 1) | Each Orally disintegrating Strips contains: Clonazepam IP 1mg | 1 Orally disintegrating Strip | M/s ZIM Laboratories Limited / M/s Alkem Laboratories Ltd. | 7.25 |
21. | Clonazepam Orally disintegrating Strips (Melzap ODS 2) | Each Orally disintegrating Strips contains: Clonazepam IP 2mg | 1 Orally disintegrating Strip | M/s ZIM Laboratories Limited / M/s Alkem Laboratories Ltd. | 13.05 |
Also Read: Launching product without Approval: DOP rejects Biocon Plea against NPPA action
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd